Since Bcl-2 inhibits mitochondrial outer membrane permeabilization and contributes to TMZ resistance, its downregulation indicates that miRNA co-treatment sensitizes GBM cells to apoptosis [50]. Here, BCL2 is linked to glioblastoma.